Sign in
WithdrawnPhase 2

Oxytocin on Approach Bias and Craving

Key facts

Who runs it
Jennifer Mitchell
Where
Berkeley, United StatesSee the site
Trial code
Status
Withdrawn
Phase
Phase 2
Started
1 Nov 2023
Ended
20 Apr 2024
Type of study
Interventional, 2 groups
Treatments tested
  • Oxytocin
  • Placebo
Record updated
6 June 2022
Why it stopped
COVID made study visits impossible during the funding period.

Who can take part

Age
21 years to 40 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 29 criteriaShow less

Who can take part

  • Healthy volunteers who are 21-40 years of age
  • If female, 10 or more alcoholic drinks must be consumed weekly
  • If male, 14 or more alcoholic drinks must be consumed weekly
  • Meets DSM-V criteria for Alcohol Use Disorder (AUD)
  • Score 8 or greater on the Alcohol Use Disorders Identification Test (AUDIT)
  • If female, must be non-lactating, not pregnant, and using a reliable contraception method (i.e. abstinence, intrauterine device [IUD], hormonal birth control, or barrier method)
  • Native English speaker
  • Right handed
  • High school graduate or equivalent
  • Able and willing to provide an informed consent
  • Able to understand and follow the instructions of the investigator

Who cannot take part

  • Positive urine drug screen (except marijuana)
  • Using cocaine, stimulants (other than nicotine and caffeine), amphetamines, hallucinogens, ecstasy, opiates, sedatives, pain pills, sleeping pills, or other psychoactive drugs within 2 weeks of the start of the study (except marijuana)
  • Current enrollment in an alcohol, or other drug treatment program or current legal problems relating to alcohol, or other drug use
  • Has received an investigational drug within 30 days of Screening Visit
  • History of major alcohol related complications within the preceding 2 years (liver failure/cirrhosis, pancreatitis, esophageal varices, etc.)
  • Has a history of atrophic rhinitis, recurrent nose bleeds, cranial surgical procedures, hypophysectomy, chronic congestion, or sinus problems
  • Has a history of cardiac arrhythmia
  • Clinically significant medical or psychiatric illness requiring treatment as determined by screening blood tests, medical history, and/or physical exam performed or reviewed by the study physician
  • Has a neurological dysfunction or psychiatric disorder (confirm with study physician)
  • Has a history of brain trauma (confirm with study physician)
  • Has an allergy or intolerance to oxytocin
  • Has a history of claustrophobia
  • SGPT/ALT or SGOT/AST values greater than 2x upper limit of normal
  • Marijuana use more than 3 times/week
  • Currently trying to quit alcohol use
  • Severely low blood (< 90/50) pressure or uncontrolled high blood pressure (>160/100)
  • BAC level > 0.00% at the beginning of screening visit (within margin of error of detection)
  • Has any MRI scanning contraindications

Where in United States

  • University of California, San FranciscoBerkeley, United States

About the trial

What the trial wants to find out

This will be a laboratory-based investigation of the behavioral and neural effects of intranasal oxytocin on craving for alcohol and approach bias in moderate to heavy alcohol using subjects. This study uses a within-subject, randomized, placebo-controlled, counterbalanced, crossover design to compare the effects oxytocin and placebo. In this way, all subjects will be scanned twice; once following oxytocin administration and once following placebo administration, and will complete a series of behavioral tasks (both in and out of the scanner) at both visits.

The 2 groups in the trial

  • Oxytocin FirstTreatment being tested

    Subjects will receive oxytocin prior to their first scanning session, and placebo prior to their second scanning session.

    Treatment: Oxytocin and Placebo

  • Placebo FirstTreatment being tested

    Subjects will receive placebo prior to their first scanning session, and oxytocin prior to their second scanning session.

    Treatment: Oxytocin and Placebo

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effects of Intranasal Oxytocin on Approach Bias and Craving in Moderate to Heavy Alcohol Drinkers
Record updated
6 June 2022